Article title: Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA
Authors: R. Sánchez-Borrego, M. V. de Diego Pérez de Zabalza, M. J. Alfageme Gullón, M. L. Alija Castrillo, M. Sánchez Prieto, S. Palacios, A. J. González Calvo, J. J. Quijano Martín and M. J. Cancelo
Journal: Climacteric
Bibliometrics: Volume 26, Number 5, pages 437-444
DOI: https://doi.org/10.1080/13697137.2023.2190508
The following sentence on p. 440 was incorrectly published as below:
As reported by patients, ospemifene significantly improved the following symptoms in comparison to the other treatments: dyspareunia (79.3% of respondents vs. 69.3% for vaginal moisturizers, p = 0.0168; and 61.6% for local HT, p < 0.0001) and decreased sexual desire (26.9% of respondents vs. 18.2% for vaginal moisturizers, p = 0.0297; and 14.0% for local HT, p = 0.0005).
This sentence has now been corrected in the online version to read:
As reported by patients, ospemifene significantly improved the following symptoms in comparison to the other treatments: dyspareunia (79.3% of respondents vs. 69.3% for local HT, p = 0.0168; and 61.6% for vaginal moisturizers, p < 0.0001) and decreased sexual desire (26.9% of respondents vs. 18.2% for local HT, p = 0.0297; and 14.0% for vaginal moisturizers, p = 0.0005).